Histology revealed no malignancy in one patient and lymphoma in another, both of whom had negative miR371a findings. One additional patient with pure teratoma and another with a microscopic ...

The accuracy of frozen section varies between 82% and 88% for BOTs and malignant tumor with most discordancy encountered for younger, premenopausal women, early-stage ovarian malignancies and mucinous ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A ...

Development of an miRNA signature for individual prognostic assessment in seminoma patients. Test characteristics of ctDNA stratified by primary or post-chemotherapy RPLND.

What’s in a Pathology Report? Pathology reports can vary depending on what type of cancer you have. You may read about different tests and terms. But most reports usually have these sections.

Pure seminoma means that there are no teratoma cells in the tumour. You will have normal Alpha fetoprotein (AFP) marker levels if you have pure seminoma. There are two categories of outlook for pure ...

Nesli Meir had a recurrent sharp pain in her lower right abdomen for some time, which was ignored. But a later CT scan revealed a benign teratoma—a monster tumour that was the size of a tennis ball.

Therapeutic approaches and outcomes in patients aged 50+ with germ cell tumours. Survival outcomes by salvage chemotherapy received.

School of Life Science and Technology, Institute of Science Tokyo, B-50, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan School of Life Science and Technology, Institute of Science Tokyo, B-50 ...

However, inadequate sources of tendon derived stem cells, ethical issue and risk of teratoma formation of embryonic stem cells or induced pluripotent stem cell, and heterogeneity of mesenchymal stem ...